## Table 1 |
|||||||||||||||||||

Phenotype of newborn cells 28 days after BrdU delivery |
|||||||||||||||||||

BrdU |
NeuN |
GFAP |
|||||||||||||||||

WT |
KO |
WT |
KO |
WT |
KO |
||||||||||||||

mean | ± | SEM | mean | ± | SEM | mean | ± | SEM | mean | ± | SEM | mean | ± | SEM | mean | ± | SEM | ||

P7 |
(n = 8) | (n = 3) | |||||||||||||||||

BrdU abs. | 62466.0 | ± | 3239.3 | 22394.0 | ± | 1455.3*** | --- | ± | --- | --- | ± | --- | --- | ± | --- | --- | ± | --- | |

% of BrdU+ | --- | ± | --- | --- | ± | --- | 57.4 | ± | 2.0 | 60.7 | ± | 0.3 | 6.3 | ± | 1.9 | 4.9 | ± | 1.2 | |

abs. co-lab. | --- | ± | --- | --- | ± | --- | 35621.2 | ± | 1643.7 | 13593.5 | ± | 845.7** | 3831.5 | ± | 1060.3 | 1140.2 | ± | 336.9** | |

P14 |
(n = 5) | (n = 4) | |||||||||||||||||

BrdU abs. | 13147.2 | ± | 1060.1 | 5671.5 | ± | 798.5** | --- | ± | --- | --- | ± | --- | --- | ± | --- | --- | ± | --- | |

% of BrdU+ | --- | ± | --- | --- | ± | --- | 64.7 | ± | 2.2 | 51.0 | ± | 5.2 | 1.9 | ± | 1.2 | 1.2 | ± | 0.8 | |

abs. co-lab. | --- | ± | --- | --- | ± | --- | 8480.3 | ± | 649.6 | 2812.2 | ± | 271.3** | 223.0 | ± | 141.4 | 84.3 | ± | 63.7 | |

P28 |
(n = 4) | (n = 3) | |||||||||||||||||

BrdU abs. | 5578.5 | ± | 708.4 | 390.0 | ± | 104.3*** | --- | ± | --- | --- | ± | --- | --- | ± | --- | --- | ± | --- | |

% of BrdU+ | --- | ± | --- | --- | ± | --- | 73.1 | ± | 3.8 | 64.8 | ± | 2.6 | 0.9 | ± | 0.1 | 2.6 | ± | 2.6 | |

abs. co-lab. | --- | ± | --- | --- | ± | --- | 4100.7 | ± | 583.4 | 261.1 | ± | 88.5*** | 45.8 | ± | 6.6 | 6.0 | ± | 6.0 | |

P40 |
(n = 3) | (n = 3) | |||||||||||||||||

BrdU abs. | 3726.0 | ± | 305.2 | 306.0 | ± | 51.3*** | --- | ± | --- | --- | ± | --- | --- | ± | --- | --- | ± | --- | |

% of BrdU+ | --- | ± | --- | --- | ± | --- | 64.6 | ± | 4.0 | 60.2 | ± | 7.1 | 8.3 | ± | 4.5 | 12.2 | ± | 6.5 | |

abs. co-lab. | --- | ± | --- | --- | ± | --- | 2420.3 | ± | 299.7 | 190.7 | ± | 53.1*** | 313.5 | ± | 186.6 | 31.3 | ± | 17.0 | |

P60 |
(n = 4) | (n = 4) | |||||||||||||||||

BrdU abs. | 2893.5 | ± | 205.5 | 222.0 | ± | 52.7*** | --- | ± | --- | --- | ± | --- | --- | ± | --- | --- | ± | --- | |

% of BrdU+ | --- | ± | --- | --- | ± | --- | 60.1 | ± | 4.1 | 46.3 | ± | 5.7 | 3.8 | ± | 2.8 | 0.0 | ± | 0.0 | |

abs. co-lab. | --- | ± | --- | --- | ± | --- | 1756.7 | ± | 219.8 | 101.3 | ± | 23.6*** | 94.9 | ± | 68.6 | 0.0 | ± | 0.0 | |

P90 |
(n = 4) | (n = 4) | |||||||||||||||||

BrdU abs. | 1770.0 | ± | 354.2 | 205.5 | ± | 81.5*** | --- | ± | --- | --- | ± | --- | --- | ± | --- | --- | ± | --- | |

% of BrdU+ | --- | ± | --- | --- | ± | --- | 66.6 | ± | 6.6 | 72.5 | ± | 14.8 | 5.7 | ± | 1.5 | 10.8 | ± | 7.9 | |

abs. co-lab. | --- | ± | --- | --- | ± | --- | 1136.2 | ± | 198.5 | 157.9 | ± | 79.2*** | 107.0 | ± | 30.1 | 29.7 | ± | 18.4 | |

P260 |
(n = 4) | (n = 3) | |||||||||||||||||

BrdU abs. | 300.0 | ± | 60.1 | 26.0 | ± | 6.2*** | --- | ± | --- | --- | ± | --- | --- | ± | --- | --- | ± | --- | |

% of BrdU+ | --- | ± | --- | --- | ± | --- | 49.7 | ± | 2.0 | 44.4 | ± | 29.4 | 9.1 | ± | 3.2 | 5.6 | ± | 5.6 | |

abs. co-lab. | --- | ± | --- | --- | ± | --- | 150.0 | ± | 33.5 | 13.3 | ± | 11.4*** | 30.1 | ± | 15.4 | 0.7 | ± | 0.7 |

Two-way ANOVA on *ln*-transformed data (**p* < 0.05, ***p* < 0.01, ****p* < 0.001 cD2KO compared to WT); Abbreviations: abs. – absolute, abs. co-lab. – absolute
number of cells co-labeled with BrdU.

Ansorg * et al.*

Ansorg * et al.* *BMC Neuroscience* 2012 **13**:46 doi:10.1186/1471-2202-13-46